[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK321681A - Fremgangsmaade til fremstilling af et antiviralt middel - Google Patents

Fremgangsmaade til fremstilling af et antiviralt middel

Info

Publication number
DK321681A
DK321681A DK321681A DK321681A DK321681A DK 321681 A DK321681 A DK 321681A DK 321681 A DK321681 A DK 321681A DK 321681 A DK321681 A DK 321681A DK 321681 A DK321681 A DK 321681A
Authority
DK
Denmark
Prior art keywords
procedure
manufacture
antiviral agent
antiviral
agent
Prior art date
Application number
DK321681A
Other languages
English (en)
Other versions
DK149191B (da
DK149191C (da
Inventor
T M Jones
A R White
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK321681(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK321681A publication Critical patent/DK321681A/da
Publication of DK149191B publication Critical patent/DK149191B/da
Application granted granted Critical
Publication of DK149191C publication Critical patent/DK149191C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK321681A 1980-07-18 1981-07-17 Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir) DK149191C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8023645 1980-07-18
GB8033218 1980-10-15
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (3)

Publication Number Publication Date
DK321681A true DK321681A (da) 1982-01-19
DK149191B DK149191B (da) 1986-03-10
DK149191C DK149191C (da) 1986-09-08

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK321681A DK149191C (da) 1980-07-18 1981-07-17 Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir)

Country Status (30)

Country Link
EP (1) EP0044543B1 (da)
AR (1) AR225680A1 (da)
AT (1) AT381025B (da)
AU (1) AU547391B2 (da)
BG (1) BG60450B2 (da)
CA (1) CA1172169A (da)
CS (1) CS229674B2 (da)
CY (1) CY1309A (da)
DD (1) DD203464A5 (da)
DE (1) DE3163982D1 (da)
DK (1) DK149191C (da)
ES (1) ES504046A0 (da)
FI (1) FI76255C (da)
GB (1) GB2080106B (da)
GR (1) GR75104B (da)
HK (1) HK95485A (da)
HU (1) HU185936B (da)
IE (1) IE51120B1 (da)
IL (1) IL63351A (da)
IT (1) IT1171399B (da)
MC (1) MC1408A1 (da)
MY (1) MY8600389A (da)
NO (1) NO155038C (da)
NZ (1) NZ197744A (da)
PH (1) PH16308A (da)
PL (1) PL135416B1 (da)
PT (1) PT73391B (da)
RO (1) RO82678A (da)
SG (1) SG72085G (da)
ZW (1) ZW17181A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
DE69313895T2 (de) * 1992-03-20 1998-02-12 Unichema Chemie Bv Formtrennzusammensetzung
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
WO1997034607A1 (en) * 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
DE602004014202D1 (de) * 2004-04-05 2008-07-10 Liomont S A De C V Lab Neue antivirale pharmazeutische zusammensetzung
EP2005824A1 (de) 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
EP3337512A1 (en) 2015-08-17 2018-06-27 Sanovel Ilac Sanayi ve Ticaret A.S. A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4141976A (en) * 1976-01-05 1979-02-27 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
PH16308A (en) 1983-09-05
FI812257L (fi) 1982-01-19
FI76255C (fi) 1990-03-14
IT1171399B (it) 1987-06-10
MY8600389A (en) 1986-12-31
SG72085G (en) 1986-05-02
BG60450B2 (bg) 1995-04-28
AU7307381A (en) 1982-01-21
DK149191B (da) 1986-03-10
AR225680A1 (es) 1982-04-15
EP0044543B1 (en) 1984-06-06
MC1408A1 (fr) 1982-07-16
IE51120B1 (en) 1986-10-01
NZ197744A (en) 1983-05-10
NO155038B (no) 1986-10-27
PT73391A (en) 1981-08-01
DE3163982D1 (en) 1984-07-12
ES8305363A1 (es) 1983-04-01
DK149191C (da) 1986-09-08
AT381025B (de) 1986-08-11
IE811617L (en) 1982-01-18
EP0044543A1 (en) 1982-01-27
CY1309A (en) 1985-12-06
CS229674B2 (en) 1984-06-18
ZW17181A1 (en) 1983-02-23
GB2080106A (en) 1982-02-03
GB2080106B (en) 1984-03-07
NO155038C (no) 1987-02-04
PL232259A1 (en) 1983-07-04
HK95485A (en) 1985-12-06
DD203464A5 (de) 1983-10-26
GR75104B (da) 1984-07-13
CA1172169A (en) 1984-08-07
IL63351A (en) 1983-10-31
RO82678A (ro) 1984-05-23
IT8148925A0 (it) 1981-07-17
NO812464L (no) 1982-01-19
PT73391B (en) 1983-06-15
ATA318081A (de) 1986-01-15
AU547391B2 (en) 1985-10-17
FI76255B (fi) 1988-06-30
ES504046A0 (es) 1983-04-01
IL63351A0 (en) 1981-10-30
HU185936B (en) 1985-04-28
PL135416B1 (en) 1985-10-31

Similar Documents

Publication Publication Date Title
DK321681A (da) Fremgangsmaade til fremstilling af et antiviralt middel
DK157876C (da) Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
DK155282C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK31282A (da) Fremgangsmaade til fremstilling af aromatiske urethaner
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK207178A (da) Fremgangsmaade til fremstilling af sojaskraa
DK37879A (da) Fremgangsmaade til fremstilling af oligoimider
DK162524C (da) Analogifremgangsmaade til fremstilling af 5-alkylthio-tetrazolderivater
DK150903C (da) Analogifremgangsmaade til fremstilling af benzisoselenazoloner
DK147513C (da) Analogifremgangsmaade til fremstilling af cefuroximestere
DK216681A (da) Fremgangsmaade til fremstilling af antitumormidler
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK31377A (da) Fremgangsmade til fremstilling af et antihypertensivt middel
DK364481A (da) Fremgangsmaade til fremstilling af caprylolactamer
DK46781A (da) Fremgangsmaade til fremstilling af antirhinovirusmidler
DK192778A (da) Fremgangsmaade til fremstilling af bisamidiner
DK151956C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK296281A (da) Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK425582A (da) Fremgangsmaade til fremstilling af amider
DK343381A (da) Fremgangsmaade til fremstilling af urinstof
DK579181A (da) Fremgangsmaade til fremstilling af diarylthiophener
DK96881A (da) Fremgangsmaade til fremstilling af et angiotensinomdannende enzym
DK153841C (da) Fremgangsmaade til fremstilling af ranitidin
DK12581A (da) Fremgangsmaade til fremstilling af kijanimicin
DK199981A (da) Fremgangsmaade til fremstilling af thiobiscarbamater